Persistent Cerebral 18-FDG PET Changes in Patients With Long COVID Presenting With Fatigue and Post Exertional Malaise
Journal of Primary Care & Community Health · 2026-06 · 17
DOI: 10.1177/21501319261458748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Primary Care & Community Health, online erschienen am 08.06.2026. Verfasst von Ravindra Ganesh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Brain, Fatigue, Positron Emission Tomography Computed Tomography, Post-Acute COVID-19 Syndrome. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Long COVID (LC) refers to the long-term symptoms occurring after SARS-CoV-2 infection and resolution of the initial disease prodrome. While LC is increasingly recognized, knowledge about its biomarkers is still limited. This study examines imaging findings in 18 F-FDG PET-CT scans in 40 patients with LC from an academic LC Clinic, for potential imaging biomarkers.
Methods
This study included patients aged 18 and older with confirmed positive SARS-CoV-2 PCR test and at least 28 days post-symptom onset. 18 F-FDG PET-CT scans were performed, and brain metabolic activity was compared to a control database to generate Z-scores. Participants were grouped based on their clinical phenotype and Z-scores of different brain regions were analyzed using t-tests.
Results
The study group was mainly female (70%), with a median age of 53 years, and predominantly non-Hispanic White (90%). Most had pre-existing conditions such as gastrointestinal, cardiovascular, endocrine, and psychiatric disorders. The findings showed significant cerebral hypometabolism in 29 patients with fatigue and post-exertional malaise (PEM), particularly in the left sensorimotor cortex (p=0.0253) and bilateral primary visual cortex (right: p=0.0096, left: p=0.0016), which persisted up to two years after infection.
Conclusions
In summary, this study identified persistent cerebral hypometabolism in LC patients, especially those with fatigue with PEM, up to two years post-infection. These results suggest that 18 F-FDG PET-CT could be a valuable tool for diagnosing and managing LC. Further research is essential to confirm these findings and improve treatment strategies for patients with LC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
- Department of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
- Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Ravindra Ganesh, Stephanie L Grach, Ivana T Croghan, Michael R Mueller
Zitieren
APA
Ganesh, R., Nair, K., Grach, S. L., Croghan, I. T., Yadav, S., Hurt, R. T., & Mueller, M. R. (2026). Persistent Cerebral 18-FDG PET Changes in Patients With Long COVID Presenting With Fatigue and Post Exertional Malaise. Journal of Primary Care & Community Health, 17. https://doi.org/10.1177/21501319261458748
Vancouver
Ganesh R, Nair K, Grach SL, Croghan IT, Yadav S, Hurt RT, et al. Persistent Cerebral 18-FDG PET Changes in Patients With Long COVID Presenting With Fatigue and Post Exertional Malaise. Journal of Primary Care & Community Health. 2026;17. doi:10.1177/21501319261458748
BibTeX
@article{Ganesh2026,
author = {Ganesh, Ravindra and Nair, Kaavya and Grach, Stephanie L and Croghan, Ivana T and Yadav, Siddhant and Hurt, Ryan T and Mueller, Michael R},
title = {Persistent Cerebral 18-FDG PET Changes in Patients With Long COVID Presenting With Fatigue and Post Exertional Malaise},
journal = {Journal of Primary Care & Community Health},
year = {2026},
volume = {17},
doi = {10.1177/21501319261458748}
}
EUVIMED